BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35522322)

  • 1. Classification of
    Reinartz M; Luckett ES; Schaeverbeke J; De Meyer S; Adamczuk K; Thal DR; Van Laere K; Dupont P; Vandenberghe R
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3772-3786. PubMed ID: 35522322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binary classification of ¹⁸F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI.
    Vandenberghe R; Nelissen N; Salmon E; Ivanoiu A; Hasselbalch S; Andersen A; Korner A; Minthon L; Brooks DJ; Van Laere K; Dupont P
    Neuroimage; 2013 Jan; 64():517-25. PubMed ID: 22982358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density.
    Curtis C; Gamez JE; Singh U; Sadowsky CH; Villena T; Sabbagh MN; Beach TG; Duara R; Fleisher AS; Frey KA; Walker Z; Hunjan A; Holmes C; Escovar YM; Vera CX; Agronin ME; Ross J; Bozoki A; Akinola M; Shi J; Vandenberghe R; Ikonomovic MD; Sherwin PF; Grachev ID; Farrar G; Smith AP; Buckley CJ; McLain R; Salloway S
    JAMA Neurol; 2015 Mar; 72(3):287-94. PubMed ID: 25622185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease.
    Ikonomovic MD; Buckley CJ; Abrahamson EE; Kofler JK; Mathis CA; Klunk WE; Farrar G
    Acta Neuropathol; 2020 Oct; 140(4):463-476. PubMed ID: 32772265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual assessment of [
    Collij LE; Salvadó G; Shekari M; Lopes Alves I; Reimand J; Wink AM; Zwan M; Niñerola-Baizán A; Perissinotti A; Scheltens P; Ikonomovic MD; Smith APL; Farrar G; Molinuevo JL; Barkhof F; Buckley CJ; van Berckel BNM; Gispert JD; ;
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2169-2182. PubMed ID: 33615397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
    Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
    Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of amyloid distribution by [
    Thal DR; Beach TG; Zanette M; Lilja J; Heurling K; Chakrabarty A; Ismail A; Farrar G; Buckley C; Smith APL
    Acta Neuropathol; 2018 Oct; 136(4):557-567. PubMed ID: 30123935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.
    Ikonomovic MD; Buckley CJ; Heurling K; Sherwin P; Jones PA; Zanette M; Mathis CA; Klunk WE; Chakrabarty A; Ironside J; Ismail A; Smith C; Thal DR; Beach TG; Farrar G; Smith AP
    Acta Neuropathol Commun; 2016 Dec; 4(1):130. PubMed ID: 27955679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
    Thurfjell L; Lilja J; Lundqvist R; Buckley C; Smith A; Vandenberghe R; Sherwin P
    J Nucl Med; 2014 Oct; 55(10):1623-8. PubMed ID: 25146124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes in
    Luckett ES; Schaeverbeke J; De Meyer S; Adamczuk K; Van Laere K; Dupont P; Vandenberghe R
    Neuroimage Clin; 2023; 37():103321. PubMed ID: 36621019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid imaging in cognitively normal older adults: comparison between (18)F-flutemetamol and (11)C-Pittsburgh compound B.
    Adamczuk K; Schaeverbeke J; Nelissen N; Neyens V; Vandenbulcke M; Goffin K; Lilja J; Hilven K; Dupont P; Van Laere K; Vandenberghe R
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):142-151. PubMed ID: 26260650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease.
    Amadoru S; Doré V; McLean CA; Hinton F; Shepherd CE; Halliday GM; Leyton CE; Yates PA; Hodges JR; Masters CL; Villemagne VL; Rowe CC
    Alzheimers Res Ther; 2020 Mar; 12(1):22. PubMed ID: 32131891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infrequent false positive [
    Ikonomovic MD; Fantoni ER; Farrar G; Salloway S
    Alzheimers Res Ther; 2018 Jun; 10(1):60. PubMed ID: 29935545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multisite study of the relationships between antemortem [
    La Joie R; Ayakta N; Seeley WW; Borys E; Boxer AL; DeCarli C; Doré V; Grinberg LT; Huang E; Hwang JH; Ikonomovic MD; Jack C; Jagust WJ; Jin LW; Klunk WE; Kofler J; Lesman-Segev OH; Lockhart SN; Lowe VJ; Masters CL; Mathis CA; McLean CL; Miller BL; Mungas D; O'Neil JP; Olichney JM; Parisi JE; Petersen RC; Rosen HJ; Rowe CC; Spina S; Vemuri P; Villemagne VL; Murray ME; Rabinovici GD
    Alzheimers Dement; 2019 Feb; 15(2):205-216. PubMed ID: 30347188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease.
    Imabayashi E; Tamamura N; Yamaguchi Y; Kamitaka Y; Sakata M; Ishii K
    Ann Nucl Med; 2022 Oct; 36(10):865-875. PubMed ID: 35821311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [(18)F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-β pathology.
    Thal DR; Beach TG; Zanette M; Heurling K; Chakrabarty A; Ismail A; Smith AP; Buckley C
    Alzheimers Dement; 2015 Aug; 11(8):975-85. PubMed ID: 26141264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer's disease, subjects with amnestic mild cognitive impairment and healthy volunteers.
    Miki T; Shimada H; Kim JS; Yamamoto Y; Sugino M; Kowa H; Heurling K; Zanette M; Sherwin PF; Senda M
    Ann Nucl Med; 2017 Apr; 31(3):260-272. PubMed ID: 28181118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flutemetamol (18F): a β-amyloid positron emission tomography tracer for Alzheimer's and dementia diagnosis.
    de Lartigue J
    Drugs Today (Barc); 2014 Mar; 50(3):219-29. PubMed ID: 24696867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies.
    Rinne JO; Wong DF; Wolk DA; Leinonen V; Arnold SE; Buckley C; Smith A; McLain R; Sherwin PF; Farrar G; Kailajärvi M; Grachev ID
    Acta Neuropathol; 2012 Dec; 124(6):833-45. PubMed ID: 23053137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [
    Bucci M; Savitcheva I; Farrar G; Salvadó G; Collij L; Doré V; Gispert JD; Gunn R; Hanseeuw B; Hansson O; Shekari M; Lhommel R; Molinuevo JL; Rowe C; Sur C; Whittington A; Buckley C; Nordberg A
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2183-2199. PubMed ID: 33844055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.